Picture of virus

Open Access research that helps to deliver "better medicines"...

Strathprints makes available scholarly Open Access content by the Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS), a major research centre in Scotland and amongst the UK's top schools of pharmacy.

Research at SIPBS includes the "New medicines", "Better medicines" and "Better use of medicines" research groups. Together their research explores multidisciplinary approaches to improve understanding of fundamental bioscience and identify novel therapeutic targets with the aim of developing therapeutic interventions, investigation of the development and manufacture of drug substances and products, and harnessing Scotland's rich health informatics datasets to inform stratified medicine approaches and investigate the impact of public health interventions.

Explore Open Access research by SIPBS. Or explore all of Strathclyde's Open Access research...

Leveraged buyouts : the new game in the City

Scouller, John (1985) Leveraged buyouts : the new game in the City. Quarterly Economic Commentary, 11 (2). pp. 74-76. ISSN 0306-7866

[img] PDF (FEC_11_2_1985_ScoullerJ)
FEC_11_2_1985_ScoullerJ.pdf
Final Published Version

Download (65kB)

Abstract

Perhaps because of the huge amounts of money involved, the phenomenon of the leveraged buyout has recently been attracting much publicity. Undoubtedly, although not a new phenomenon, it is a growing one and is of increasing interest not only to the press but also to governments, regulatory bodies, unions, and academics. This perspective examines some of the more important aspects of leveraged buyouts.